SCOTUS Tosses Challenge To Abortion Pills Access

NBC News reports:

The Supreme Court on Thursday rejected a challenge to the abortion pill mifepristone, meaning the commonly used drug can remain widely available.

The court found unanimously that the group of anti-abortion doctors who questioned the Food and Drug Administration’s decisions making it easier to access the pill did not have legal standing to sue. As a result, the lawsuit will be dismissed.

By throwing out the case on such grounds, the court avoided reaching the legal merits of whether the FDA acted lawfully in lifting various restrictions, including one making the drug obtainable via mail, meaning the same issues could yet return to the court in another case.

Read the full article.

BREAKING: Supreme Court upholds full access to Mifepristone abortion pill pic.twitter.com/4PXwxxX1uP

— Bloomberg Law (@BLaw) June 13, 2024

The Supreme Court rejected a lawsuit challenging the Food and Drug Administration’s approach to regulating the abortion pill mifepristone with a ruling that will continue to allow the pills to be mailed to patients without an in-person doctor’s visit. https://t.co/Nz8gCfKGGT

— KWWL (@KWWL) June 13, 2024

The Supreme Court's first decision of the day is FDA v. AHM! Justice Kavanaugh unanimously holds that the anti-abortion plaintiffs in this case lack standing to challenge the FDA's regulations allowing access to mifepristone for medication abortion. https://t.co/qr1mhowf0F pic.twitter.com/HhoVSy50RP

— Mark Joseph Stern (@mjs_DC) June 13, 2024